HVJ-E将阿波利波蛋白d与抗瘤作用联系起来
Airi Ishibashi1, Noriko Ohta2, Yuko Uegaki1
1Division of Gene Therapy Science, Department of Genome Biology, Osaka University Graduate School of Medicine, Suita, Osaka, Japan.
Journal for immunotherapy of cancer
|June 20, 2025
概括
紫外线 (UV) 照射的日本包膜血液凝结病毒 (HVJ-E) 疗法通过诱导Apolipoprotein d (Apod) 表达抑制瘤生长. 阿波德通过调节NKG2D配体基因和T细胞激活来增强抗瘤免疫力.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 分子生物学分子生物学
背景情况:
- 病毒疗法利用病毒杀死癌细胞并刺激免疫反应.
- 非复制性病毒疗法的精确机制,如紫外线辐射日本血液凝结病毒 (HVJ-E) 包裹,仍然不完全理解.
研究的目的:
- 阐明UV辐射HVJ-E诱导的抗瘤效应的分子媒介.
- 调查阿波利波蛋白d (Apod) 在调解HVJ-E抗瘤活性中的作用.
主要方法:
- 用RNA测序,基因淘汰和药物诱导基因表达系统来识别关键基因.
- 用全基因组的CRISPR库查,现场生物化,质谱,流细胞计和小鼠模型来分析Apod的功能.
- 研究了Apod与ERK2的相互作用及其对核转位和NKG2D-连接体表达的影响.
主要成果:
- 紫外线照射的HVJ-E通过瘤细胞中的干扰素调节因子7 (Irf7) 诱导的Apod表达产生抗瘤作用.
- 通过增加NKG2D结合体基因,Apod显著抑制瘤生长,即使在对HVJ-E耐药的瘤中也是如此.
- 阿波德与ERK2结合,抑制其核转位和Importin7,从而上调NKG2D连接体,减少瘤生长.
- 与Apod和抗OX40抗体的联合治疗显示出强大的抗瘤活性和T细胞激活.
结论:
- 这项研究揭示了HVJ-E调解抗瘤效应的分子途径,涉及Irf7和Apod.
- 这些发现为开发新型治疗策略提供了洞察力,以增强抗瘤免疫力.
更多相关视频
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
9.4K
08:55Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
9.6K
相关概念视频
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
Mechanisms of Retrovirus-induced Cancers
5.3K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.3K
Rous Sarcoma Virus (RSV) and Cancer
5.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.4K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
